300404 博济医药
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.1282.6883.3166.1803.919
总资产报酬率 ROA (%)2.0661.8072.3024.1192.457
投入资产回报率 ROIC (%)2.3792.0722.6294.8223.230

边际利润分析
销售毛利率 (%)32.61233.33637.93243.22043.695
营业利润率 (%)5.7033.1734.61114.50810.522
息税前利润/营业总收入 (%)5.8283.0955.59614.42611.149
净利润/营业总收入 (%)9.0474.8926.91813.4189.548

收益指标分析
经营活动净收益/利润总额(%)119.40097.999102.61281.140100.216
价值变动净收益/利润总额(%)9.92615.79715.2755.00710.713
营业外收支净额/利润总额(%)-0.002-0.05220.4960.1101.309

偿债能力分析
流动比率 (X)2.1462.2802.3362.5851.524
速动比率 (X)1.5971.7231.7752.0371.145
资产负债率 (%)33.10231.41029.76925.6400.353
带息债务/全部投入资本 (%)23.22822.01920.43616.70424.136
股东权益/带息债务 (%)324.868348.080379.442486.142301.605
股东权益/负债合计 (%)197.123212.970226.979278.926167.868
利息保障倍数 (X)46.868-40.563-27.485-146.67222.899

营运能力分析
应收账款周转天数 (天)70.93966.68769.34563.47083.396
存货周转天数 (天)162.948178.493216.752236.171226.743